Regenerative Medicine+212 662 100 418
← Catalogue

Retatrutide

weight loss protocol
Metabolism & energy · Metabolism & weight

The triple GLP-1/GIP/glucagon agonist — the most pronounced weight loss of its class.

iThe essentials in 10 seconds

  • Most potent molecule in its class: acts on 3 receptors (GLP-1, GIP, glucagon)
  • Greatest weight loss among current treatments (up to 24% in trials)
  • Subcutaneous injection, once weekly, with gradual dose escalation
  • Mandatory medical follow-up (digestive tolerance, pancreas, gallbladder)

IWhat is Retatrutide?

RetatrutideThe triple agonist

Retatrutide mimics three natural hormones involved in satiety and metabolism: GLP-1 and GIP (which suppress appetite and slow digestion) and glucagon (which increases energy expenditure). This triple action makes it more effective than single agonists. It is undergoing advanced clinical evaluation for obesity.

Recent treatment, data still maturing. Reserved for strict prescription and medical follow-up — never for self-medication.

IIThe benefits

Weight lossThe most pronounced result

Major reduction in appetite and caloric intake: the greatest weight loss in the class (up to ~24%).

Satiety & appetiteHunger under control

Slows gastric emptying and acts on hunger centers: rapid and lasting feeling of fullness.

Blood glucoseSugar control

Strongly improves insulin sensitivity — major benefit in type 2 diabetes and prediabetes.

MetabolismThe internal burner

Glucagon action increases energy expenditure at rest (unlike GLP-1 agonists alone).

Liver & lipidsThe de-fatted liver

Reduces liver fat and lipid profile — useful in steatosis (fatty liver).

Risk factorsCardiometabolic protection

Improvement in blood pressure, triglycerides, and inflammation — targets of metabolic syndrome.

IIIRecommendations & how to use

How to useDosage · route · storage
Reconstitution: lyophilized vial + bacteriostatic water (dilution provided during consultation)

Route: subcutaneous injection (abdomen/thigh), once weekly, preferably the same day · Escalation: start low and increase gradually to limit digestive effects · Storage: refrigerated (2–8 °C).
Treatment requires medical follow-up (tolerance, hydration, protein intake).

Prices (indicative)
DosageEuroDollarDirham
10 mg60 €65 $650 DH
15 mg78 €85 $850 DH

Indicative exchange rates — final price confirmed during consultation.

IVThe two protocols

Weight loss protocolGradual escalation · once weekly

Goal: achieve lasting weight loss by increasing doses in steps, to minimize digestive effects.

Dose: start at the lowest dose, then step up every 4 weeks according to tolerance (e.g., 2 → 4 → 8 → 12 mg)
Frequency: 1 injection/week, same day
Duration: several months then maintenance phase

Follow-up: weight, waist circumference, digestive tolerance, labs (blood glucose, lipids, liver).

Metabolic & activity protocolBody composition

Goal: preserve muscle mass during weight loss.

Physical activity + sufficient protein (1.2–1.6 g/kg/day) throughout treatment
Continue once weekly frequency, adjusted to training
Check for absence of muscle loss at reassessment

The peptide does not excuse lifestyle habits: it facilitates them.

VProtocol rules

Good habits
  • Sufficient protein intake to preserve muscle
  • Drink regularly — hydration limits digestive effects
  • Fiber-rich diet, smaller and more frequent meals
  • Regular physical activity (walking + strength training)
  • Record weight, tolerance, and satiety for follow-up
To avoid / precautions
  • Never self-medicate: medication requiring strict medical follow-up
  • Do not exceed the dose or accelerate escalation
  • Eating fatty/fried foods or overeating: triggers nausea and vomiting
  • Excessive alcohol (pancreas, liver)
  • Pregnancy, breastfeeding, history of pancreatitis or medullary thyroid cancer: contraindication

VIYour journey in 3 steps

Step 1 · Consultation
Assessment & laboratory workup

Metabolic evaluation, contraindications, weight goals, injection training.

Step 2 · Escalation & follow-up
1 injection/week

Stepwise increase every 4 weeks, according to tolerance and results.

Step 3 · Reassessment
Continuation or maintenance

Weight, body composition, labs — decision on next phase.